Good laboratory practice is the central dogma of all laboratory research and investigation - it's your commitment to regulators - and poor laboratory controls are a common cause of 483 observations and preapproval inspection failures.
Kevin Robinson
Advertisement
Articles by Kevin Robinson
by Kevin Robinson For "me too" manufacturers, the growth opportunity is in Europe ? and in biogenerics.
by Kevin Robinson, BioPharm International As we approach the end of 2002, biotechnology companies continue to be the standard bearers for innovation in the pharmaceutical industry.
Advertisement
Latest Updated Articles
GLPs and the Importance of Standard Operating ProceduresAugust 1st 2003
- European Editor's Report ? An Industry Comes of Age
November 15th 2002
- Market Views: A Rocky Road for Generics
January 15th 2003
Advertisement
Advertisement
Trending on BioPharm International
1
Sanofi Begins Construction of EU-Backed Insulin Plant in Frankfurt
2
Nano24's Inhaled EXO-CD24 Cuts ARDS Mortality in Phase 2b Trial
3
TaiMed’s Anti-CD4 Antibody TMB-365 Reduces HIV Viral Load in Phase 1, Supporting Long-Acting Combination Regimens
4
Akeso's Ivonescimab Enters Phase 2/3 Biliary Tract Cancer Trial in US
5